FMR LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,233,538
-29.0%
26,822
-11.2%
0.00%
Q2 2023$1,736,520
-23.2%
30,216
-49.9%
0.00%
Q1 2023$2,261,626
+175.4%
60,310
+105.8%
0.00%
Q4 2022$821,210
-0.2%
29,308
+0.1%
0.00%
Q3 2022$823,000
-19.8%
29,276
-0.8%
0.00%
Q2 2022$1,026,000
-3.6%
29,507
-0.4%
0.00%
Q1 2022$1,064,000
+35366.7%
29,625
+23600.0%
0.00%
Q2 2021$3,000
+50.0%
1250.0%0.00%
Q1 2021$2,000
+100.0%
125
+150.0%
0.00%
Q3 2020$1,00050
+614.3%
0.00%
Q1 2020$070.0%0.00%
Q4 2019$0
-100.0%
7
-85.7%
0.00%
Q3 2019$1,000
-66.7%
49
-67.3%
0.00%
Q1 2019$3,000
-99.9%
150
-99.9%
0.00%
Q4 2017$2,855,000
-35.1%
148,408
-51.1%
0.00%
-100.0%
Q1 2017$4,397,000
-81.9%
303,257
-77.0%
0.00%
-66.7%
Q4 2016$24,269,000
-36.9%
1,317,541
-35.0%
0.00%
-40.0%
Q3 2016$38,464,000
-0.5%
2,027,627
-15.5%
0.01%0.0%
Q2 2016$38,664,000
+29.5%
2,398,531
-3.6%
0.01%
+25.0%
Q1 2016$29,858,000
-0.2%
2,488,161
+18.4%
0.00%0.0%
Q4 2015$29,911,000
+18.7%
2,101,956
-2.5%
0.00%0.0%
Q3 2015$25,195,000
-23.1%
2,155,302
+15.7%
0.00%0.0%
Q2 2015$32,754,000
+2089.4%
1,863,161
+1763.2%
0.00%
Q1 2015$1,496,000
+28.9%
100,0000.0%0.00%
Q4 2014$1,161,000
-0.3%
100,0000.0%0.00%
Q3 2014$1,165,000100,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders